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Abstract
A variety of human diseases are associated with gammaherpesviruses, including neoplasms of lymphocytes (e.g. Burkitt’s
lymphoma) and endothelial cells (e.g. Kaposi’s sarcoma). Gammaherpesvirus infections usually result in either a productive
lytic infection, characterized by expression of all viral genes and rapid cell lysis, or latent infection, characterized by limited
viral gene expression and no cell lysis. Here, we report characterization of endothelial cell infection with murine
gammaherpesvirus 68 (cHV68), a virus phylogenetically related and biologically similar to the human gammaherpesviruses.
Endothelial cells supported cHV68 replication in vitro, but were unique in that a significant proportion of the cells escaped
lysis, proliferated, and remained viable in culture for an extended time. Upon infection, endothelial cells became non-
adherent and altered in size, complexity, and cell-surface protein expression. These cells were uniformly infected and
expressed the lytic transcription program based on detection of abundant viral gene transcripts, GFP fluorescence from the
viral genome, and viral surface protein expression. Additionally, endothelial cells continued to produce new infectious
virions as late as 30 days post-infection. The outcome of this long-term infection was promoted by the cHV68 v-cyclin,
because in the absence of the v-cyclin, viability was significantly reduced following infection. Importantly, infected primary
endothelial cells also demonstrated increased viability relative to infected primary fibroblasts, and this increased viability
was dependent on the v-cyclin. Finally, we provide evidence for infection of endothelial cells in vivo in immune-deficient
mice. The extended viability and virus production of infected endothelial cells indicated that endothelial cells provided a
source of prolonged virus production and identify a cell-type specific adaptation of gammaherpesvirus replication. While
infected endothelial cells would likely be cleared in a healthy individual, persistently infected endothelial cells could provide
a source of continued virus replication in immune-compromised individuals, a context in which gammaherpesvirus-
associated pathology frequently occurs.
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Introduction
Endothelial cells create a physical barrier on the luminal surface
of blood and lymphatic vessels. This barrier must be traversed by
blood-borne pathogens and immune cells trafficking between
tissues and the bloodstream. Many herpesviruses require systemic
spread for persistence within a host, and therefore must cross such
an endothelial cell barrier. To date, herpesviruses have been
implicated as potential initiators of arterial injury, endothelial
dysfunction, and local inflammation, possibly contributing to the
pathogenesis of atherosclerosis [1–4]. Human cytomegalovirus
(HCMV), a betaherpesvirus, infects endothelial cells in vivo. Studies
have shown that infected endothelial cells play a role in HCMV
dissemination and pathogenesis [5]. Endothelial cells exhibit
regional specialization in gene expression and morphology
depending on the local physiologic demands of their respective
organs and tissues [6]. In light of this diversity, it is not surprising
that endothelial cells from different tissues differ in their
susceptibility to HCMV infection [7]. Kaposi’s sarcoma-associated
herpesvirus (KSHV), a human gammaherpesvirus, also infects
endothelial cells in vivo. More importantly, KSHV is the causative
agent of the endothelial cell neoplasm, Kaposi’s sarcoma (KS).
The murine gammaherpesvirus, cHV68, has been detected in
aortic endothelium after infection of apoE deficient mice, as well
as on the luminal surface of explanted aortas infected in vitro [8].
While a relationship between gammaherpesviruses and endothelial
cells has been noted, the role of endothelial cells in chronic
gammaherpesvirus infection and pathogenesis is ill-defined.
Gammaherpesviruses are a lymphotropic family of viruses
associated with a broad spectrum of malignancies and lympho-
proliferative diseases. These oncogenic viruses persist for the life of
the host by establishing and maintaining a latent infection.
Because gammaherpesviruses are extremely host-specific, studying
the human viruses Epstein-Barr virus (EBV) and KSHV in non-
human systems does not mimic natural infection. cHV68 is a
natural pathogen of wild murid rodents and therefore provides a
valuable small animal model of gammaherpesvirus infection [9–
13]. This virus has important biological and genetic similarities to
the human gammaherpesviruses, and results in a variety of
pathologies in defined mouse models. Primary cHV68 infection is
characterized by virus replication in lung epithelial cells, and the
establishment of latency in B cells, dendritic cells, and macro-
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epithelial cells [17]. The role of endothelial cells in cHV68
infection has not been explored to date.
At the cellular level, gammaherpesvirus infection encompasses
two broadly defined outcomes: productive, lytic replication and
non-productive, latent infection. During lytic replication, viral
DNA is amplified and host cell machinery is utilized for the
production of viral progeny. Viral genes are actively transcribed
and translated, contributing to new virus production. Ultimately,
the cell is lysed and infectious virus released. In light of the fact
that this process occurs quickly (24 to 48 hours in vitro) our
understanding of virus-host interactions during primary infection
is quite limited. During latency, viral DNA is not amplified, but
instead is maintained as a nuclear episome in latently infected
cells, and little viral gene transcription occurs. Latently infected
cells remain intact and do not produce new infectious virus.
Furthermore, it is thought that these long-lived latent cells may
serve as the major mechanism by which gammaherpesviruses
promote life-long infection of their hosts.
Here we characterize cHV68 infection of endothelial cells. To
date, in vitro infection of most cells with cHV68 supports significant
viral replication and results in complete cell lysis (data not shown,
van Dyk). We have infected both primary endothelial cells and
endothelial cell lines and demonstrated that they produce
comparable amounts of virus as fibroblasts. However, whereas
fibroblasts were mostly lysed by 36–48 hours post-infection, a
significant percentage of infected endothelial cells remained intact.
Analysis of endothelial cell lines revealed that these intact cells 1)
were actively infected and undergoing the lytic transcriptional
program, 2) continued to proliferate for a prolonged time after
infection, 3) were altered in morphology and cell-surface protein
expression, compared to uninfected endothelial cells, and 4)
continued to release infectious virions as far as 30 days post-
infection. In the absence of the cHV68 viral cyclin, endothelial cell
viability was significantly decreased after infection, indicating that
an active viral process was responsible for promoting the outcome
of infection in endothelial cells. Of major significance, we also
provided evidence of endothelial cell infection in primary cells and
in vivo in immune-deficient mice. These data demonstrated that
endothelial cells supported persistent, productive gammaherpes-
virus infection, an outcome not previously reported for cHV68 or
other gammaherpesviruses. Together, these data indicated the
potential of the endothelial cell as a critical cell type in cHV68
pathogenesis, and open a new avenue of research into herpesvirus
manipulation of endothelial cell biology.
Results
Endothelial cells supported cHV68 replication
Endothelial cells are heterogeneous in nature, express unique
surface antigens, and differ in their susceptibility and response to
infection by various pathogens [6]. In light of this diversity, we
investigated endothelial cell lines from various anatomic locations,
and from BALB/c and C57BL/6 mice, for their ability to support
cHV68 replication. We analyzed the outcome of cHV68 infection
in endothelial cell lines from lung (CD3), brain capillary (MB114),
and lymph node (SVEC) by single-step and multi-step growth
assays. Single step growth proceeded with kinetics similar to
previously published infection of the fibroblast cell line, NIH 3T12
cells [18] in each of the three endothelial cell lines analyzed
(Fig. 1A, top panel). Though equivalent numbers of cells were
plated per well, the differences amongst the endothelial cell lines in
titer at time zero were not surprising given that cell lines grow at
varying rates and to varying densities. A comparison of viral titers
at 36 hours revealed that the three endothelial cells lines produced
titers comparable to those achieved in 3T3 fibroblast cells.
Additionally, multi-step growth in MB114 and CD3 endothelial
cells was similar to growth in 3T3 fibroblasts (Fig. 1A, bottom
panel). These data demonstrated that cHV68 is capable of
replication in endothelial cells infected in vitro.
Using a GFP-labeled virus, we next sought to determine if the
percentage of infected endothelial cells was comparable to
percentage of infected fibroblasts. Following infection of MB114
endothelial cells and 3T12 fibroblasts, cells were analyzed for
expression of GFP from the cHV68 genome by flow cytometry. At
24 and 48 hours post-infection the majority of endothelial cells
and fibroblasts expressed GFP (Fig. 1B). These data indicated that,
like fibroblasts, endothelial cells were uniformly infected and
supported the cHV68 lytic transcription program.
A population of endothelial cells remained intact
following cHV68 infection and uniformly expressed lytic
antigens
Uninfected endothelial cells and fibroblasts grew as adherent
monolayers (Fig. 2A, top panel). However, in infected endothelial
cell cultures, we observed a population of intact, phase-bright, and
non-adherent cells as early as 96 hours post-infection, whereas only
cellular debris remained in the infected fibroblast cultures (data not
shown). At six days post-infection, we collected non-adherent cells
and cellular remains by centrifugation. After washing, we
resuspended this material in complete media for culture and
analysis. The cells harvested from the infected endothelial cultures
appeared as individual, intact cells suspended in culture, whereas
the material harvested from the infected fibroblast cultures
appeared as clumps of cellular debris (Fig. 2A, bottom panel). Prior
to centrifugation, we measured cell viability by trypan blue
exclusion. Very few infected fibroblasts remained as viable, non-
adherent cells at six days post-infection (Fig. 2B). However, a
significant proportion of endothelial cells remained as viable, non-
adherent cells at six days post-infection. When MB114 endothelial
cells were treated with a non-toxic dose of phosphonoacetic acid
Author Summary
Various human diseases are associated with gammaherpes-
virus infections, including neoplasms of lymphocytes (e.g.
Burkitt’s lymphoma) and endothelial cells (e.g. Kaposi’s
sarcoma). Gammaherpesvirus infection of cells usually
results in either productive infection that is characterized
by new virus production and rapid destruction of the host
cell, or latent infection that is characterized by long-term
carriage of viral DNA in intact cells that do not produce
virus.Here, we characterizeendothelial cell infection using a
small animal model of gammaherpesvirus infection and
disease. While infection of endothelial cells resulted in virus
production as most cells do, infection of this cell type was
unique in that cells remained intact and continued to
proliferate. These intact, infected endothelial cells were
significantly altered in appearance and gene expression
compared to uninfected cells, changes predicted to impact
endothelial cell growth and function. Endothelial cells were
unique in their ability to support this type of persistent
infection. These data demonstrate an additional mecha-
nism, beyond latency, by which gammaherpesviruses may
achieve long-term propagation, particularly in conditions of
immune suppression. Our results suggest persistently
infected cells as a therapeutic target for prevention/
treatment of chronic disease, and may provide a mouse
model for future testing.
Gammaherpesvirus Infection of Endothelial Cells
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most cells remained adherent, and there were significantly fewer
detached, viable cells (Fig. 2B). PAA alone had no effect on the
viability, adherence, or phenotype of uninfected MB114 cells in
culture (data not shown). These data revealed that a population of
endothelial cells became non-adherent and remained viable at six
days post-infection, whereas fibroblasts were destroyed by cHV68
infection. Additionally, this outcome of infection in endothelial cells
was influenced by late viral gene expression, as most cells remained
adherent in the presence of PAA.
Next we determined the status of virus replication in the viable
and non-adherent cells. Cells collected at six days post-infection
were analyzed by flow cytometry for expression of the cHV68
glycoprotein, gp150, which is expressed during the lytic transcrip-
tion program on the surface of infected cells [19]. Cell viability was
also determined using propidium iodide (PI), a cell impermeant
dye that is excluded from intact cell membranes. In these
experiments we also included the S11E cell line, a mouse B cell
lymphoma line which harbors latent cHV68, and therefore is
negative for gp150 surface expression [20]. The majority of
MB114 endothelial cells and 3T12 fibroblasts were positive for
surface gp150 expression (Fig. 2C). While 3T12 fibroblasts were
mostly PI positive, MB114 endothelial cells excluded PI. These
data indicated that endothelial cells which remained viable at six
days post-infection were undergoing the lytic transcription
program and were not latent or uninfected.
At 12 days post-infection we determined the viability of cells
collected and cultured at six days post-infection. PI staining of S11
cells, after six days in culture, revealed that 51.7% (62.5 SEM) of
cells were PI negative and thus viable. PI staining of post-infection
fibroblasts, treated in parallel with infected endothelial cells,
revealed that only 14.5% (61.5 SEM) of the cells harvested
remained intact. In contrast, PI staining of post-infection
endothelial cells revealed that 92.5% (60.3 SEM) of the cells
harvested were intact and viable (Fig. 2D). Analysis of the viral
replication program in MB114 endothelial cells at 12 days post-
infection revealed that the majority of cells continued to express
gp150 (Fig. 3C). Therefore, infection of endothelial cells with
cHV68 resulted in a population of cells that escaped lysis and
remained intact as far as 12 days post-infection, while undergoing
the lytic transcription program.
Intact endothelial cells were productively infected and
underwent a continued lytic program
The observed viability of endothelial cells after cHV68 infection
could be the result of escape from infection or latent infection of
Figure 1. Endothelial cells supported cHV68 replication. In vitro growth assays of cHV68 in MB114, SVEC, and CD3 endothelial cells. Cell were
infected at the indicated MOI with either wildtype cHV68 (A) or cHV68-GFP (B) and harvested at the indicated times. (A) Samples were multiply
freeze-thawed prior to quantification by plaque assay on NIH 3T12 cells. Top panel, cHV68 titer 36 hours post-infection in 3T3 fibroblasts compared
to MB114, SVEC, and CD3 endothelial cells. n=2–3. (B) Cells infected with cHV68-GFP were analyzed by flow cytometry for GFP expression at 24 and
48 hours post-infection. Fluorescence was determined relative to cells infected with wildtype cHV68 (grey). Histograms are representative of two
independent infections.
doi:10.1371/journal.ppat.1000152.g001
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endothelial cells, we performed RT-PCR analysis of viral gene
transcripts. The cHV68 M2 gene transcript is synthesized during
both lytic and latent infection, as are the polymerase III (pol III)
transcripts encoded at the left end of the viral genome [21,22].
Latently infected S11 cells contained both pol III-1 and M2
transcripts (Fig. 3A). We detected these transcripts in 3T3
fibroblasts at 24 and 36 hours post-infection, as well as from the
3T3 cellular debris harvested at six days post-infection, while no
cellular b-actin transcript was detected from infected 3T3 cells at
36 hours post-infection. No RNA could be detected from infected
3T3 debris at 12 days post-infection, whereas we recovered RNA
from infected MB114 cells as far as 12 days post-infection. Pol III-
1 and M2 transcripts were detected in infected MB114 cells at 24
and 36 hours post-infection and from the intact, cultured cells at
six and 12 days post-infection. We detected b-actin RNA in
infected MB114 cells at 24 and 36 hours post-infection, but not at
six and 12 days post-infection. However, we detected another
cellular mRNA transcript, cyclophilin A, at six days post-infection
in 3T3 fibroblasts and MB114 cells (Fig. S2), and comparable
detection of the cellular 18S rRNA transcript was observed in all
conditions. Gradual loss of the cellular b-actin transcript in viable
cells was not surprising given that b-actin has been documented to
vary significantly in the setting of virus infection [23], and selective
Figure 2. A population of endothelial cells remained intact following cHV68 infection. Non-adherent cells were collected at six days post-
infection (MOI of 5 PFU/cell), cultured, and viability determined at six and 12 days post-infection. Status of cHV68 replication was determined at six
days post-infection. (A) Bright field images of 3T3 fibroblasts, MB114 endothelial cells, and SVEC endothelial cells prior to infection (top panel) and at
six days after cHV68 infection (bottom panel). Magnification of 200X. Infected cells were harvested by centrifugation and resuspended in fresh media
prior to imaging. (B) Percentage of cells infected that were non-adherent and viable at six days post-infection. Where indicated, cells were treated
with PAA after one hour of infection. Non-adherent cells were collected at six days post-infection and viability determined as percentage of trypan
blue excluding cells. A significantly lower percentage of all fibroblast lines analyzed were viable at six days post-infection as compared to all
endothelial cell lines analyzed (*p,0.001). In the presence of PAA, a significantly lower percentage of endothelial cells were non-adherent and viable
at six days post-infection (up=0.018). Data is from 2–3 independent experiments per cell line. (C) Following collection at six days post-infection, cells
were centrifuged and stained for surface expression of gp150 (top panel) or with propidium iodine (PI) (bottom panel). Latent S11E cells do not
express lytic viral proteins and are a negative control for gp150 expression, as well as a positive control for viable cells. Fluorescence was determined
relative to unstained cells (grey) and numbers reflect percent positive staining. Histograms are representative of two independent experiments. (D)
Cultures of non-adherent cells at 12 days post-infection were stained with PI and viability determined by flow cytometry as percent PI negative cells.
n=3 per cell line. Cultures of endothelial cells remained significantly more viable than fibroblasts at 12 days post-infection (*p,0.001). S11s were
analyzed as a positive control for viable cells.
doi:10.1371/journal.ppat.1000152.g002
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infection [24–28]. Analysis of viral gene transcripts indicated that
those endothelial cells which remained intact after cHV68
infection contained viral gene transcripts as far as 12 days post-
infection.
To determine whether the intact, infected endothelial cells were
undergoing active viral replication, we analyzed infected cells for
the expression of early and late lytic replication-associated M3 and
gB. As predicted, 3T3 fibroblasts, which support lytic replication,
expressed both M3 and gB (Fig. 3B). In contrast, S11 B cells,
which contain latent cHV68, did not express either M3 or gB.
Intact, infected MB114 endothelial cells not only expressed M3
and gB early (36 hours), but also at six and 12 days post-infection.
A faster migrating gB-specific band was also detected at six days
post-infection, and may indicate differential glycosylation or
degradation. Additionally, infected MB114 endothelial cells were
positive for surface protein expression of gp150 at both 12 and 24
days post-infection (Fig. 3C). Our analysis of lytic protein
expression indicated that endothelial cells which remained intact
after cHV68 infection expressed early and late lytic proteins,
indicating that not only did cHV68 infected endothelial cells still
contain virus, these cells also expressed viral proteins indicative of
active viral replication, and not latency.
To further test the status of viral replication in endothelial cells,
we infected MB114 endothelial cells with GFP-cHV68 and
collected the intact, non-adherent cells at six days post-infection.
GFP expression is driven by the CMV immediate early promoter
and has been demonstrated to be expressed only during lytic
infection [29]. At the time of harvest, these cells uniformly
expressed GFP (Fig. 3D histogram) and continued to do so at 20
days post-infection, (Fig. 3D micrographs). Therefore, the non-
adherent endothelial cells which remained intact after cHV68
infection did not escape infection and were not latently infected.
Intact, infected endothelial cells released new infectious
virus particles
After establishing that the intact endothelial cells harvested at
six days post-infection were indeed infected, we determined
whether these cells produced mature virions. Transmission
electron microscopy (TEM) of these cells revealed virions at
various stages of maturation throughout the nucleus and
cytoplasm of 100% of the 20 cells imaged at 12 days post-
Figure 3. Endothelial cells which were viable after cHV68 infection were productively infected. (A) MB114 cells contained viral gene
transcripts as far as 12 days post-infection. RT-PCR analysis of viral gene transcripts. 100 ng of total RNA from mock infected and infected MB114 and
3T3 cells and from S11 cells was added to each of the RT reactions along with primers specific for the viral transcripts polymerase III-1 and M2, and
the cellular transcripts b-actin and 18S. No RT and no template controls are indicated. (B) MB114 cells contained viral proteins as far as 12 days post-
infection. Immunoblot of lytic viral protein expression. 10 mg of total protein from mock infected and infected MB114 and 3T3 cells and from S11 cells
were loaded per lane and blots probed with antibodies to the lytic cHV68 proteins M3 (top) and gB (middle), and mouse b-actin (bottom) as a
loading control. Mock infected cells were collected at 24 hours. Latent S11 cells do not express lytic viral proteins and served as a negative control. (C)
At the indicated times post-infection, MB114 cells were analyzed for gp150 surface expression by flow cytometry. Fluorescence was determined
relative to unstained cells (grey). Histograms are representative of two independent infections. (D) Six days post-infection with GFP-cHV68, MB114
cells were collected and analyzed by flow cytometry for GFP expression. Cells were cultured and brightfield (top) and fluorescent (bottom) images
taken at 20 days post-infection, 100X magnification. Fluorescence was determined relative to cells infected with wildtype cHV68 (grey), and
histogram is representative of two independent infections.
doi:10.1371/journal.ppat.1000152.g003
Gammaherpesvirus Infection of Endothelial Cells
PLoS Pathogens | www.plospathogens.org 5 September 2008 | Volume 4 | Issue 9 | e1000152infection (Fig. 4A). TEM analysis of 3T12 fibroblasts at 36 hours
post-infection demonstrated that the cells were lysed by infection,
with no intact membranes, and mature virions were not evident in
any discernable subcellular structures. Unlike fibroblasts, endo-
thelial cells which remained intact after cHV68 infection
contained virions at various stages of maturation throughout the
cytoplasm and nucleus at 12 days post-infection.
The culture conditions we established for maintaining the non-
adherent cells included centrifugation and resuspension in fresh
media every six days (Fig. S1). To test the contribution of non-
adherent cells to virus production, aliquots of the supernatants
were collected for measurement of cell-free virus. A culture of
latently infected S11 cells did not yield any detectable cell-free
virus after six days in culture by plaque assay (Fig. 4B). In contrast,
after six days in culture (12 days post-infection), cell-free
supernatant from infected MB114 cells yielded significant viral
titer, and this titer was significantly higher than that of supernatant
taken from infected 3T3 cultures. Therefore, endothelial cells
continued to release new infectious virions for at least 12 days post-
infection. Infected endothelial cell supernatant contained 100-fold
more virus than that of a lysed, infected, fibroblast culture.
Intact endothelial cells undergo transient proliferation in
culture after cHV68 infection
After the initial observation that cHV68 infection of several
endothelial cell lines from different anatomic locations resulted in
a population of cells that escaped lysis, we focused our analysis on
this outcome in MB114 endothelial cells. Beginning at the time of
collection (day six post-infection), we counted intact, trypan blue
excluding cells every three days. Infected MB114 cells remained
viable for at least 30 days post-infection (Fig. 5A).
During this course of infection, the number of intact cells in the
culture increased from 7.08610
5 (60.16 SEM) to 8.51610
6
(60.28 SEM) during the first six days of culture, a ten-fold
increase. A corresponding increase in the percentage of membrane
viable cells also occurred during this time. Subsequent to day 12
post-infection, the total number of intact cells began to decrease, as
did the overall viability of the culture (Fig. 5A). The observed
Figure 4. Viable cHV68-infected endothelial cells produced and released new infectious virus particles. (A) MB114 cells contained
virions at various stages post-infection throughout the nucleus and cytoplasm. Transmission electron micrographs (TEM) of 3T12 cells and MB114
cells infected with MOI of 5. 36 hours post-infection, adherent 3T12 cells were collected and combined with non-adherent material in media (left
panel). At six days post-infection, only non-adherent MB114 cells remained (middle and right panel). These cells were collected and cultured until 12
days post-infection. Pelleted cells were fixed in glutaraldehyde for TEM. Black arrows indicate virions. (B) MB114 cells released significantly more virus
into the media as far as 12 days post-infection than 3T3 fibroblasts (p=0.001). Non-adherent 3T3 fibroblasts and MB114 cells were collected at six
days post-infection, washed twice, and resuspended in complete RPMI. At 12 days post-infection, cell-free supernatant titers were determined by
plaque assay. Supernatant titer from latently infected S11 B cells, cultured in the same manner as infected 3T3 cells and MB114 cells was below the
limit of detection for the plaque assay (0.5 log10 PFU/mL, indicated by dashed line).
doi:10.1371/journal.ppat.1000152.g004
Gammaherpesvirus Infection of Endothelial Cells
PLoS Pathogens | www.plospathogens.org 6 September 2008 | Volume 4 | Issue 9 | e1000152increase in both intact cell number and percent viability during the
first six days of culture, concurrent with positive gp150 staining
(Fig. 2C and Fig. 3C), indicated that endothelial cells were intact
and proliferating in culture while maintaining the lytic transcrip-
tion program.
To further examine the proliferation observed during the first
six days of culture, we stained MB114 cells with carboxyfluor-
oscein (CFSE) prior to infection. CFSE is a fluorescent molecule
used to measure cell proliferation, in that each time a cell divides,
the two daughter cells contain half the CFSE of the parent cell.
S11 cells demonstrated a drop in CFSE signal intensity after six
days in culture, consistent with cell division. At the time of harvest
(day six post-infection), MB114 cells also demonstrated a drop in
CFSE signal intensity consistent with multiple cell divisions
(Fig. 5B). After six more days in culture (12 days post-infection)
CFSE signal intensity dropped further, consistent with continued
cellular proliferation. Thus, endothelial cells which remained
intact after cHV68 underwent multiple rounds of proliferation.
Note that by 30 days post-infection, however, the viability of the
culture was quite low in comparison to earlier time points (Fig. 5A).
To further test the fate of the surviving endothelial cells, we
examined viability of infected cells by staining with annexin V and
PI (Fig. 5C). MB114 cells were 92.4% (60.6 SEM) viable (annexin
V negative, PI negative) at two days post-infection and 72.5%
(614.5 SEM) viable at four days post-infection. At six days post-
infection all MB114 cells were non-adherent and 31.0% (610.74
SEM) of these non-adherent cells were viable. In contrast to
MB114 cells, dying cells dominated infected 3T12 cultures at six
days post-infection These data indicate that many MB114 cells
died early during infection, and in agreement with our
proliferation data (Fig. 5A and 5B) the population of viable cells
increased to 86.4% (60.6 SEM) of the culture by 12 days post-
infection. However, by 30 days post-infection dying cells finally
dominated the infected culture. These data support that the subset
of cells surviving and proliferating at six days post-infection were
unique their extended survival, but did not remain viable
indefinitely. Of significance, during the course of this infection
most of the cells expressed the lytic glycoprotein gp150 on their
surface at both early and late time points (Fig. 2C and Fig. 3C).
Moreover, the percentage of cells expressing gp150 did not change
markedly with time (Fig. 2C and Fig. 3C). These data indicate that
the vast majority of viable, infected endothelial cells were
Figure 5. Endothelial cells exhibited prolonged viability and proliferated after cHV68 infection. Viability and proliferation of an
endothelial cell line collected at six days post-infection (MOI of 5 PFU/cell) were determined every three days of culture. (A) Non-adherent MB114
endothelial cells collected at six days post-infection remained viable as far as 30 days post-infection. Viability (left axis) and live cell number (right axis)
by trypan blue exclusion counts were measured every three days of culture. n=3. (B) MB114 cells proliferated after infection. MB114 cells were
stained with CFSE and analyzed by flow cytometry for green fluorescence prior to infection (day 0), and at six and 12 days post-infection. Unstained
cells analyzed in parallel were consistent in autofluorescence throughout the analysis. S11 B cells, harboring latent cHV68 genome, were stained and
analyzed in parallel as a positive control. n=2 per cell line. (C) Analysis of viability in MB114 cells (top panel) and 3T12 cells (bottom panel) following
cHV68 infection. Viability was determined by double staining of PI and annexin V, and gated on unstained cells. The results are representative of 2–4
independent experiments.
doi:10.1371/journal.ppat.1000152.g005
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neither latently infected nor had escaped infection.
Intact endothelial cells were altered in size, shape, and
surface marker expression after cHV68 infection
To investigate the morphologic differences between uninfected
endothelial cells and the endothelial cells harvested at six days
post-infection, we quantified cell size and internal granularity by
flow cytometric determination of forward versus side scatter.
Uninfected MB114 cells exhibited a broad range of light scatter,
indicative of a cell population diverse in size and internal
granularity. In contrast, infected cells were very uniform in
forward and side scatter (Fig. 6A). PAA treatment immediately
following MB114 infection resulted in significantly fewer cells
becoming non-adherent (Fig. 2B). Like the uninfected MB114
cells, MB114 cells treated with PAA following infection exhibited a
broad range of forward and side scatter (Fig. 6A). Thus, cHV68
infection of endothelial cells resulted in a uniform population of
cells with altered morphology, and this outcome was dependent on
productive viral infection and late viral gene expression.
To further investigate the differences between uninfected
endothelial cells and the intact cells harvested six days after
infection, we compared the expression of cell-surface proteins on
these two cell populations by flow cytometry. Because the cells
harvested at six days post-infection persisted in culture as non-
adherent cells, we chose to investigate surface expression of the
Figure 6. Infected and viable endothelial cells were altered in size, shape, and surface protein expression. Flow cytometric analysis of
morphology and surface protein expression of non-adherent endothelial cells collected at six days post-infection. (A) MB114 cells were altered in size
and granularity by cHV68 infection. Flow cytometric determination of forward and side scatter properties of MB114 cells collected at six days post-
infection. MB114 cells treated with phophonoacetic acid (PAA) one hour after infection were collected and analyzed at six days post-infection. n=2.
(B) MB114 cells were altered in surface protein expression after cHV68 infection. Uninfected and infected MB114 cells harvested at six days post-
infection were analyzed for cell surface expression of Thy1, ICAM-1, and VCAM-1 by flow cytometry. Fluorescence was determined relative to
unstained cells (grey). Results are representative from three independent experiments.
doi:10.1371/journal.ppat.1000152.g006
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CD54) and vascular cell adhesion molecule-1 (VCAM-1, CD106).
Additionally, we analyzed cells for surface expression of Thy1, a
cell surface protein which is upregulated on the surface of
activated endothelial cells and functions in cell-cell interactions
[30–32]. Uninfected MB114 cells expressed ICAM-1, VCAM-1,
and Thy1 (Fig. 6B). In contrast, infected endothelial cells
expressed neither ICAM-1 nor VCAM-1, but did express Thy1.
Based on these data, cHV68 infected endothelial cells down-
regulate cell surface expression of two adhesion molecules, while
maintaining surface expression of an activation marker.
In the absence of the viral cyclin, endothelial cell viability
after cHV68 infection is reduced
We demonstrated that cHV68 infection of endothelial cells
resulted in a population of intact cells which persisted in culture as
non-adherent cells and continued to produce new virus. Our
analysis of endothelial cell infection in the presence of PAA
indicated that this outcome is influenced by viral DNA replication
and/or late gene synthesis (Fig. 2B and Fig. 4A). To begin
dissecting the mechanism of persistent cHV68 in endothelial cells
infected in vitro, we tested the role of the cHV68 viral cyclin (v-
cyclin) in this system. We measured expression of the cHV68 v-
cyclin in infected MB114 endothelial cells and infected fibroblasts
by RT-PCR and western analysis. Notably, the cHV68 v-cyclin
gene transcript and protein were detectable in infected endothelial
cells and fibroblasts (Fig. 7A and Fig. S3A).
To determine the role of the v-cyclin in endothelial cell
infection, we infected MB114 cells with either wildtype cHV68 or
a v-cyclin deficient cHV68 (v-cyclin.STOP cHV68) [18]. Cells
were harvested at six days post-infection and cultured as described
previously. As per previously published reports in fibroblasts, we
determined that the v-cyclin was dispensable for cHV68 growth in
endothelial cell lines by multi-step growth assays (data not shown).
Cultures of MB114 cells infected with wildtype virus were 48.5%
(60.61 SEM) viable at day six, 79.4% (60.36 SEM) viable at day
nine, 91.3% (60.26 SEM) at day 12, and 62.2 % (61.33 SEM) at
day 15 post-infection. In contrast, cultures of MB114 cells infected
with v-cyclin.STOP cHV68 were 15.1% (62.093 SEM) viable at
day 6, 8.4% (61.767 SEM) viable at day 9, 18.4% (65.304 SEM)
viable at day 12, and 27.7% (65.817 SEM) viable at day 15 post-
infection. Therefore, in the absence of the v-cyclin, endothelial cell
viability was significantly impaired after cHV68 infection.
Because viability of MB114 cells after infection was impaired in
the absence of the v-cyclin, we next determined the effect of this
Figure 7. Optimal viability of endothelial cells after cHV68 infection requires the viral cyclin. (A) MB114 cells contained the cHV68 v-
cyclin transcript. RT-PCR analysis of the cHV68 v-cyclin transcript. Total RNA was isolated from infected MB114 cells and 3T3 cells at the indicated
times post-infection, as well as from latently infected S11 B cells. 100 ng of RNA from each sample was subjected to RT-PCR analysis with primers
specific for the v-cyclin transcript. As a loading control, we also amplified the cellular transcript b-actin. No RNA could be isolated from cultured 3T3
cells at 12 days post-infection. No RT and no template controls are indicated. (B & C) Viability and persistent viral replication in the presence or
absence of the v-cyclin. MB114 cells were infected with wildtype (black) or v-cyclin.STOP cHV68 (grey) at an MOI of 5 PFU/cell. Cells were harvested at
six days post-infection by centrifugation from supernatant, and cultured in complete RPMI. Every six days cells were centrifuged to remove
supernatant for titer (C) and stained with propidium iodine (PI) every three days (B). Viability of post-infection cultures was determined as percentP I
negative cells by flow cytometry. Significant differences in viability were observed between wildtype cHV68 and v-cyclin.STOP infections at day six
(p,0.001), day nine (p,0.001), day 12 (p,0.001), and day 15 (p=0.002). n=3 for wildtype infection and n=4 for v-cylin.STOP infection. (C) Cell free
virus titer of supernatants from wildtype cHV68 (black) and v-cyclin.STOP cHV68 (grey) infected cells was determined by plaque assay at the indicated
times post-infection. Significant differences observed at day 12 (p=0.008) and day 24 (p=0.042). n=2.
doi:10.1371/journal.ppat.1000152.g007
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Cell free supernatants from infected MB114 cells were titered by
plaque assay (Fig. 7C). Infections with both wildtype and v-
cyclin.STOP virus resulted in persistent viral production up to 30
days post-infection. Total viral titers from v-cyclin.STOP
infections were significantly less than wildtype infections at 12
and 24 days, however, an equivalent amount of virus was
produced per cell as in wildtype cHV68 infections. Cell surface
protein expression of ICAM-1, VCAM-1, and Thy1 was the same
following infection with either wildtype or v-cyclin.STOP virus
(Fig. 6B and Fig. S3B), thus the v-cyclin was not required for the
surface phenotype of infected endothelial cells and the surface
phenotype of infected endothelial cells did not predict survival.
Therefore, upon infection, the primary function of the v-cyclin was
to promote the viability of endothelial cells.
Primary endothelial cells were infected in vivo, and ex
vivo demonstrated prolonged viability while supporting
cHV68 growth
Given that immortalized endothelial cell lines are inherently
different from endothelial cells in vivo, we next determined the
outcome of cHV68 infection in primary endothelial cells. Primary
endothelial cells were isolated from C57/BL6 mouse lungs and
characterized as per previously published methods (Fig. S4).
First, we determined if primary lung endothelial cells could
support growth of wildtype cHV68 by multi-step growth assay
(Fig. 8A). Because of the apparent role for the v-cyclin in infection
of endothelial cell lines, we also analyzed growth of v-cyclin.STOP
virus in primary endothelial cells. Infection proceeded with kinetics
comparable to previously published infection of NIH 3T12
fibroblasts [18]. Growth curves did not differ between wildtype
and v-cyclin.STOP virus. These data revealed that primary
endothelial cells supported growth of cHV68, irrespective of the v-
cyclin.
Second, we analyzed the percent of cells that remained viable
after cHV68 infection at a low MOI. Immediately following
removal of the viral inoculum (t=0), mouse embryonic fibroblasts
(MEFs) and primary lung endothelial cells did not differ
significantly in viability (p.0.05) (Fig. 8B). However, at 48 hours
post-infection with wildtype cHV68, primary lung endothelial cells
were significantly more viable than MEFs (p,0.001), and
remained significantly more viable at 96 (p,0.05) and 120 hours
post-infection (p,0.001). Notably, endothelial cells infected with
the v-cyclin deficient cHV68 had reduced viability at 48, 96, and
120 hours post-infection. Given that cells were infected at a very
low MOI, it was not surprising that a proportion of MEFs
(28.5%611.1 SEM) were viable at 96 hours post-infection.
However, unlike endothelial cells, MEFs were mostly lysed by
120 hours post-infection with wildtype virus. These data demon-
strate that primary endothelial cells surpass MEFs in viability
following cHV68 infection, and that this outcome is promoted by
the v-cyclin.
Lastly, we examined lung endothelial cells following acute
cHV68 infection in vivo. Our in vitro studies revealed that viable,
infected endothelial cells were not latently infected, but uniformly
supported a lytic viral program (Fig. 2C, Fig. 3C and 3D). Because
persistent viral infection and lytic viral antigen expression is likely to
be cleared by an intact immune response, we analyzed endothelial
cell infection in lung tissues of immune-deficient CD8-alpha null
mice. At six days post-intranasal infection, lung cells enriched for
those bearing the endothelial cell marker CD31 were analyzed
alongside the remaining CD31 depleted lung cells. Given the
possibility that a small percentage of non-endothelial cells can
transiently express CD31 (i.e. macrophages and neutrophils), we
depleted the CD31 positive cell population of these potential
contaminating cells and analyzed resultant cell populations by flow
cytometry (Fig. S5B). PCR analysis with single copy sensitivity for
cHV68 gene50 (Rta) was performed to determine the frequency of
viral genome positive cells in the CD31-enriched and remaining
CD31-depleted lung cell populations (Fig. 8C). Data from this
analysis revealed that approximately 1/102 CD31-enriched cells
were viral genome positive, whereas 1/525 remaining CD31-
depleted lung cells contained viral DNA. Thus, these data support
that a surprisingly large proportion of lung endothelial cells were
viral genome positive following in vivo infection.
To further demonstrate that these viral genome positive cells are
actively infected, and to exclude the possibility of endocytic uptake
of virus or abortive infection, we performed RT-PCR analysis on
endothelial enriched and depleted lung cells (Fig. 8D). The
transcript for the endothelial cell marker CD31 was robustly
detected in the endothelial enriched lung cells from each of the
four mice analyzed, whereas a very low level of this transcript was
detected from the CD31 depleted lung cells of only one out of the
four mice analyzed. In combination with flow cytometric analysis
(Fig. S5B), these data support that our enrichment strategy was
effective in isolating CD31+ cells from total lung cells. Addition-
ally, the viral pol III-1 transcript was detected from both
endothelial cell enriched and depleted lung cells of cHV68
infected mice, and was absent from lungs of mock infected mice.
Detection of viral gene transcripts from lung cells indicates virus
infection of these cells. Notably, within each infected mouse, pol
III-1 detection was comparable between endothelial enriched and
CD31-depleted lung cell populations, suggesting that detection of
this viral transcript in the endothelial cell population was not due a
few contaminating infected non-endothelial cells. Taken together,
these data demonstrate cHV68 infection of endothelial cells in vivo.
Discussion
Herpesviruses have been implicated as potential initiators of a
variety of endothelial pathologies [1–4]. Given the intimate
interactions observed between herpesviruses and endothelial cells,
and the systemic spread of cHV68 during infection, we character-
ized the outcome of endothelial cell infection with cHV68, a small
animal model for the human gammaherpesviruses. While cHV68
replicated comparably in endothelial cells and fibroblasts up to
36 hours post-infection, infected cultures of endothelial cells had a
high percentage of viable, non-adherent cells that remained
following infection. Of significance, these viable, non-adherent cells
had not simply escaped infection, but instead were actively infected,
as determined by the presence of multiple markers of the lytic
replication program. While the absolute number of viable, infected
endothelial cells varied among different cell lines and primary cells,
the prolonged viability of endothelial cells in comparison to
fibroblasts was remarkably consistent in endothelial cell lines from
distinct anatomic locations, as well as in primary endothelial cells.
Furthermore, optimal survival of both endothelial cell lines and
primary endothelial cells was dependent on the presence of the
cHV68 v-cyclin, indicating that this outcome was a process actively
promoted by virus infection.
This conserved outcome of endothelial cell infection is
particularly striking given that endothelial cells display phenotypic
heterogeneity in structure and function depending on anatomic
location [33–35]. Based on the persistent infection observed in
diverse endothelial cell lines, and heightened viability of primary
endothelial cells following infection, we propose that cHV68 may
have evolved machinery to specifically promote persistent infection
in endothelial cells.
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viral reservoir of HCMV [36–40], suggesting a role for HCMV-
infected endothelial cells in viral spread and persistence. Addition-
ally, recent reports implicate circulating endothelial progenitor cells
as potential reservoirs of KSHV and possible precursors of KS
spindle cells [41,42]. However, the specific mechanisms by which
infected endothelial cells contribute to the pathogenesis of these
human viruses remains unclear. Murine cHV68 pathogenesis
involves dissemination from the lung to lymph nodes, spleen, and
peritoneum [12,15]. In light of this systemic spread, cHV68 likely
encounters an endothelial cell barrier.
The human gammaherpesvirus KSHV causes a serious endothe-
lial cell malignancy, KS, which predominantly occurs in immune-
compromised individuals (e.g. AIDS patients). KS tumors are
comprised of distinctive spindle cells of endothelial origin and a
variable inflammatory infiltrate [43–46]. KSHV is detected primarily
in the endothelial component of the lesion, and though most of these
cells harbor latent KSHV, a subset of them enter the lytic cycle
[47,48]. While there is precedent for a mixed infection type within
KS tumors (i.e. both lytic and latent infection), the history of the
lytically infected cells remains elusive, though recent reports point to
circulating endothelial progenitor cells [41,42]. In vitro,e n d o t h e l i a l
cell infection with KSHV is predominantly latent [43,49–51].
However, when these cells are transferred into mice, they show
evidence of lytic gene expression and virus production [52].
Because viral DNA replication and/or late gene synthesis were
important for endothelial cell outcome of cHV68 infection (Fig. 2B
and Fig. 6A), our findings indicate that an active viral process
occurred within the cells to yield these changes. Consistent with
this hypothesis, we identified that the cHV68 v-cyclin is required
for optimal endothelial cell viability after cHV68 infection in vitro.
The cHV68 v-cyclin promotes cell cycle progression in primary
Figure 8. Primary endothelial cells were infected in vivo, and demonstrated prolonged viability while supporting cHV68 growth ex
vivo. Multi-step growth assay of cHV68 in primary C57/BL6 lung endothelial cells (A) and corresponding cell viability (B). Primary cells were infected at
an MOI of 0.05 PFU/cell with either wildtype cHV68 or v-cyclin.STOP cHV68, harvested at the indicated times, and trypan blue exclusion counts
performed (B). (A) Samples were multiply freeze-thawed prior to quantification by plaque assay on NIH 3T12 cells. n=3. (B) At 0, 48, 96, and 120 hours
post-infection, trypan blue exclusion counts were performed on primary lung endothelial cells and primary MEFs infected with either wildtype or v-
cyclin.STOP cHV68 at an MOI of 0.05 PFU/cell. n=3. Limiting dilution-PCR of viral DNA (C) and RT-PCR (D) analysis of endothelial enriched (E) and
depleted (D) lung cells from CD8-alpha knockout mice at six days post-intranasal infection. (C) Frequency of viral genome-positive cells was
determined by LD-PCR. Percentage of positive PCR reactions are indicated on the y axis and the number of cells analyzed is indicated on the x axis.
For each cell dilution, 12 PCR reactions were analyzed. The frequency of viral genome positive cells was determined by Poisson distribution indicated
by the dashed line at 63.2%. Data represent the averages of three separate infected animals. Error bars represent standard errors of the mean. (D)
Total RNA was isolated from D and E populations and 100 ng of RNA subjected to RT-PCR analysis with primers specific for the cHV68 pol III-1
transcript and the cellular transcripts CD31 and b-actin. Results are shown from three infected and one mock infected mouse.
doi:10.1371/journal.ppat.1000152.g008
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[18]. While the v-cyclin is critical for reactivation from latency, to
date the v-cyclin has been dispensable in all assays of lytic
replication in vitro [53,54]. Given the lytic nature of endothelial cell
infection, the contribution of the v-cyclin to optimal endothelial
cell viability after cHV68 infection indicates a role for the v-cyclin
outside of its requirement in reactivation from latency. Addition-
ally, the apparent role of the v-cyclin in this prolonged infection of
both endothelial cell lines and primary lung endothelial cells may
explain the slight decrease in lung titers that resulted in mice
infected with low doses of v-cyclin.STOP cHV68 and other v-
cyclin mutant viruses compared to wildtype cHV68 [55].
Although the precise mechanism by which the v-cyclin promotes
endothelial cell viability is unknown at this time, it is possible that
the v-cyclin provides growth cues that allow for anchorage-
independent growth of endothelial cells after cHV68 infection.
While our initial analysis focused on the role of the v-cyclin, it is
very likely that additional viral genes facilitate persistent endothelial
cell infection. Lead candidates include the anti-apoptotic viral bcl-2
gene M11 and the viral GPCR (ORF 74), whose homologs in KSHV
have been implicated in endothelial cell survival and transformation
[56–59]. Additional candidates for optimal endothelial cell infection
are the ribonucleotide reductase homologs, ORF 60 and 61 of
cHV68. Although the role of these genes in cHV68 infection of
endothelial cells is currently untested, the MCMV ribonucleotide
reductase homolog is required for in vivo replication and pathogenesis
of this endothelial cell-tropic virus [60].
One of the most noticeable alterations of the persistently
infected endothelial cells described here is the extent of change in
their cellular morphology and properties. Though we did not test
the oncogenic potential of these cells, endothelial cells achieved
anchorage-independent growth, a property frequently associated
with oncogenic transformation. These cells also underwent
significant changes in protein expression on the cell surface, with
down-regulation of the cellular adhesion proteins ICAM-1 (CD54)
and VCAM-1 (CD106). While there was decreased expression of
ICAM-1 and VCAM-1, changes in cell surface expression were
not global, since Thy1 expression remained positive on these cells
(Fig. 6B). It is worth noting that infection of endothelial cells with
KSHV results in down-regulation of MHC class I, PE-CAM
(CD31), and ICAM-1 (CD54), but not LFA-3 (CD58) or Fas
(CD95), and the viral genes K3 and K5 have been demonstrated
to regulate this outcome [61–66]. The contribution of the mK3
gene of cHV68 to persistent endothelial cell infection remains
untested. Down-regulation of certain surface markers but not
others during viral infection indicates a specific phenomenon,
rather than global down-regulation, and provides further evidence
that an active process was responsible for the observed endothelial
cell outcome of cHV68 infection.
While cHV68 may have evolved mechanisms that promote
persistent infection of endothelial cells (e.g. the v-cyclin), it is also
possible that endothelial cells have a cellular program that limits
the cellular lysis typically observed during productive infection.
This putative cellular adaptation may be particularly important in
limiting destruction of blood vessel integrity during viral infection.
A recent report of host cell response to cHV68 in three different
cell types (fibroblasts, endothelial precursor cells and macrophages)
identified 148 genes whose expression was altered in endothelial
precursor cells, but not macrophages or fibroblasts [67]. Taken
together with the unique endothelial cell outcome of cHV68
infection reported here, these data make a compelling argument
for cell type specific responses to productive cHV68 infection.
We have provided evidence for cHV68 infection of endothelial
cells in vivo at early times post-infection. Interestingly, infected cells
(including endothelial cells) were not abundant in acutely infected
lung tissue, as little to no GFP was detected by flow cytometric
analysis of unfractionated lung cells after infection with a GFP-
marked virus (data not shown), but required sensitive PCR
methods for detection. Our in vitro analysis demonstrated a change
in surface phenotype of infected endothelial cells which could
correspond to substrate detachment and release into circulation.
This is an intriguing idea in light of published reports of circulating
endothelial cells and progenitor endothelial cells in virus infection.
Our in vitro studies implicated endothelial cells as a persistent
source of virus production, however, the extent to which
endothelial cells contribute to cHV68 persistence in vivo, and to
what degree it might be influenced by host immune status, are
important issues that remains to be addressed. While it is unlikely
that an intact immune response would permit such long-term
expression of viral antigens in vivo, we hypothesize that persistently
infected endothelial cells could provide a significant source of
continued virus replication in immune-compromised individuals
(i.e. AIDS patients), a context in which gammaherpesvirus-
associated pathology frequently occurs.
Given the unusual properties of these viable and infected
endothelial cells (e.g. anchorage-independent growth and altered
cell surface protein expression), it will be important to critically
address the potential role of endothelial cells as a reservoir for
infection in vivo in both immune-competent and immune-deficient
individuals.
In conclusion, our data provide evidence for prolonged
gammaherpesvirus infection in endothelial cells. This outcome
appears to be the result of a specific interaction between cHV68
and endothelial cells, as it is promoted by a viral gene (the cHV68
v-cyclin) and, to date, is unique to endothelial cells. These data
further refine the concept of gammaherpesvirus infection and
demonstrate that a gammaherpesvirus can undergo robust
productive replication in the context of prolonged host cell
viability. Identification of intermediate outcomes of gammaher-
pesvirus infection, such as the one we have described here, has
major implications for our understanding of the nature of
gammaherpesvirus infection as it relates to specific cell types.
Such a course of infection provides an additional mechanism,
beyond latency, by which gammaherpesviruses can achieve long-
term propagation.
Materials and Methods
Viruses and tissue culture
Mouse fibroblast cell lines 3T3 (ATCC CRL-1658) and 3T12
(ATCC CCL-164) and mouse endothelial cell lines MB114 [68],
SVEC4-10 (ATCC CRL-2181), and CD3 [69] were cultured in
Dulbecco’s Modified Eagle Media (DMEM) supplemented with 5%
FBS(Hyclone,Logan, UT),2 mML-glutamine, 10 U/mLpenicillin,
and 10 mg/mL streptomycin sulfate. S11 [20] and S11E tumor cells
[22] were cultured in RPMI 1640 medium (Gibco) supplemented
with 10% FBS, 50 mM b-mercaptoethanol, 1 mM sodium pyruvate,
2 mM L-glutamine, 10 U/mL penicillin, and 10 mg/mL streptomy-
cin sulfate (complete RPMI). Mouse embryonic fibroblasts were
isolated from C57/BL6 mice as previously described [70] and
cultured in DMEM supplemented with 10% FBS, 2 mM L-
glutamine, 10 U/mL penicillin, 10 mg/mL streptomycin sulfay7te,
and 250 ng/mLfungizone.Isolation, characterization,and culture of
primary endothelial cells from C57/BL6 mice was done according to
previously published methods [71] and is described in Protocol S1,
Text S1 and Figure S3A.
cHV68 WUMS (ATCC VR-1465) and all recombinant viruses
were grown and titered as previously described [72]. DK3TET
2
Gammaherpesvirus Infection of Endothelial Cells
PLoS Pathogens | www.plospathogens.org 12 September 2008 | Volume 4 | Issue 9 | e1000152cHV68 (cHV68-GFP) containing a GFP cassette under the
control of an immediate early CMV promoter was generated
and characterized by Dr. Phillip Stevenson [73]. cHV68
containing a stop codon within ORF 72 (v-cyclin.STOP.
cHV68) was previously described [18].
All infections were carried out at a multiplicity of infection
(MOI) of 5 plaque forming units (PFU) per cell. Inoculum was
removed after one hour of infection at 37uC, cell monolayers
rinsed three times with sterile phosphate buffered saline (PBS), and
complete media added. Intact and non-adherent cells were
collected at six days post-infection, at which time cells and media
were collected, counted to determine post-infection viability by
trypan blue exclusion, and then centrifuged for 10 minutes at
2086g. Cell pellets were washed twice in sterile PBS and then
resuspended in complete RPMI at a concentration of 5610
5 viable
cells/mL for continued culture. Cells were counted every three
days of culture, and adjusted to a concentration of 5610
5 viable
cells/mL. Every six days of culture, cells were counted and
centrifuged for 10 minutes at 2086g to remove cell-free cHV68
and cellular debris. Pellets were washed twice in sterile PBS and
resuspended in RPMI at a concentration of 5610
5 viable cells/
mL. Culture scheme is depicted in supplement (Fig. S1).
Viral titer by plaque assay
To measure virus replication, infected samples were analyzed by
plaque assay at various times post-infection. To measure cell-free
virus titer from infected cultures, supernatants were collected every
six days of culture and analyzed by plaque assay. Samples were
thawed, serially diluted, and plated onto NIH 3T12 cells in 12 well
plates in triplicate. Infection was performed at 37uC for one hour.
Cells were overlaid with a 1:1 mix of DMEM and carboxymeth-
ylcellulose plus fungizone (final concentration 250 ng/mL). Plates
were incubated for seven days at 37uC. On day seven,
carboxymethylcellulose was removed, and plates were stained
with 0.35% methylene blue in 70% methanol and rotated for 15–
20 minutes, before rinsing with water and counting on a light box.
All titers were determined in parallel with a laboratory standard.
Flow cytometry
For propidium iodine (PI) viability studies, cells were washed
twice in PBS (five minutes, 10006g), resuspended in a 0.5 mg/mL
PI solution, and incubated for 15 minutes. Following incubation,
cells were centrifuged (five minutes, 10006g) and washed in a
solution of PBS, 2% fetal calf serum, and 0.1% NaN3 (buffer A).
Cells were fixed in 1% paraformaldehyde, and analyzed by flow
cytometry. For two parameter viability analysis, cells were washed
in 1X annexin V binding buffer (BD Bioscience, San Jose, CA),
resuspended in 0.5 mg/mL PI and 5 mL annexin V-FITC (BD
Bioscience), incubated for 15 minutes, washed in binding buffer,
fixed in 1% paraformaldehyde, and analyzed by flow cytometry.
For carboxyfluorescein (CFSE) proliferation studies, MB114
cells and Sll cells were washed twice in PBS (five minutes, 10006g)
and resuspended in a solution of PBS and 2% fetal calf serum
(buffer B) at a concentration of 1610
6 cells per mL. An equal
volume of 4 mM CFSE in buffer B was added to the cell suspension
(2 mM final concentration) and pipet mixed. After three minutes
the labeling reaction was quenched with an equal volume of fetal
calf serum for 30 seconds, and buffer B was added for a total
volume of 50 mL. Cells were centrifuged (five minutes, 10006g),
resuspended in buffer B, and aliquots collected for day 0 analysis.
Remaining, labeled cells were resuspended in complete media and
cultured. Labeled MB114 cells were infected at an MOI=5 PFU/
cell. Infected cells were harvested as described at day six post-
infection and analyzed by flow cytometry at six and 12 days post-
infection. Stained and unstained S11 cells were analyzed at the
same time as a positive control.
For surface marker staining, cells were washed twice in buffer A
(five minutes, 10006g) and resuspended in primary antibody
(1:200 in buffer A, 25% 24G2 [74]). The following primary
antibodies were used: CD106-biotin (Rat, IgG2a k, clone 429
(MVCAM.A)), CD54-FITC (Armenian hamster, IgG1 k, clone
3E2), Thy1.2-APC (Rat, IgG2a k, clone 53-2.1) (BD Bioscience),
monoclonal mouse anti-cHV68 gp150 (mouse IgG2a, a kind gift
from Dr. Phillip Stevenson) [75]. Cells were then incubated for
45 minutes at room temperature. Following incubation, cells were
centrifuged twice in buffer A (five minutes, 10006g), resuspended
in either buffer A or secondary staining reagent in buffer A (1:500),
and incubated for 20–30 minutes at room temperature. Secondary
staining reagents were either streptavidin-APC (BD Bioscience) or
anti-mouse IgG2a-FITC (Rat IgG1 k, clone R19-15) (BD
Bioscience). Cells were centrifuged twice in buffer A (five minutes,
10006g) and analyzed by flow cytometry.
For forward versus side scatter analysis, MB114 cells harvested
at six days post-infection were analyzed. Uninfected MB114 cells
were detached from flasks with 0.5 mM EDTA and analyzed in
parallel with infected cells. In certain experiments, to determine
the effect of viral DNA replication and/or late gene synthesis on
forward and side scatter properties, MB114 cells were treated with
200 mg/mL phosphonoacetic acid (PAA) after one hour of
infection. At six days post-infection, non-adherent cells were
harvested and counted by trypan blue exclusion to determine the
percent of cells infected that were viable and non-adherent at time
of harvest. Cells which remained adherent to the flask were then
detached with 0.5 mM EDTA, combined with the harvested non-
adherent cells, and analyzed by flow cytometry for forward and
side scatter properties. Effective block of late gene synthesis was
confirmed by plaque assay titer of treated cells. Viral titer was
reduced 96.2% after 24 hours and 99.9% after six days as
compared to untreated cells. 10 micron control beads were run in
parallel with each experiment (Beckman Coulter, Fullerton, CA).
Western analysis
Cells were collected and boiled in Laemmli buffer for
10 minutes. Total protein concentration of each cell extract was
determined by Lowry assay (DC protein assay kit, Bio-Rad,
Hercules, CA). 10–20 mg of total protein per extract was separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Proteins were electrotransferred (ThermoFisher Scientific, Ports-
mouth, NH) to PVDF membranes (Millipore, Billerica, MA) and
blocked in PBS with 0.05% Tween-20 and 5% nonfat milk for one
hour at room temperature. Western blots for cHV68 protein
expression were incubated with 10 mg/mL monoclonal mouse
anti-cHV68 gB [76] (kind gift of Dr. Phillip Stevenson),
monoclonal mouse anti-cHV68 M3 at 1:50, polyclonal rabbit
anti-cHV68 v-cyclin at 1:2000 (kind gifts of Dr. Herbert Virgin),
and monoclonal antibody to mouse b-actin at 1:1000 (Sigma
Chemical, St. Louis, MO). Blots were washed for 45 minutes in
PBS with 0.05% Tween-20, then incubated with donkey anti-
mouse or donkey anti-rabbit antibodies at 1:6000 for one hour.
Blots were then washed in PBS containing 0.1% Tween-20 for
45 minutes. Proteins were visualized using an ECL Plus Western
blotting detection kit (Amersham Pharmacia Biotech).
RNA Isolation and RT-PCR Amplification
Total RNA was extracted from S11 cells, infected NIH 3T3
cells, infected MB114 cells, and murine lung cell fractions using
mirVANA
TM miRNA Isolation kit (Ambion, Austin, TX), per
manufacturer’s instructions. Amplifications were conducted using
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GTC ACC GAT CC 39, cHV68 polIII-1 reverse 59 GGA AGT
ACG GCC ATT TC 39, cHV68 M2 forward 59 TAA GGA CCT
CGT AGA GAT TGG C 39, cHV68 M2 reverse 59 ACG TTA
AAG TCC CCA TGG AAG C 39, cHV68 v-cyclin forward 59
ATT AGC ACT GGG CGT TTC ATG 39, cHV68 v-cyclin
reverse 59 GAC CTC CGT CAG GAT AAC AAC 39, mouse b-
actin forward 59 GCC ACC AGT TCG CCA TGG 39, mouse b-
actin reverse 59 CAA TGC CAT GTT CAA TGG GGT A 39,
mouse 18S forward 59 AGA TCA AAA CCA ACC CGG TGA 39,
mouse 18S reverse 59 GGT AAG AGC ATC GAG GGG GC 39,
mouse cyclophilin A forward 59 ATT TGG CTA TAA GGG
TTC CTC 39, mouse cyclophilin A reverse 59 ACG CTC CAT
GGC TTC CAC AAT 39, mouse CD31 forward 59 AGG GGA
CCA GCT GCA CAT TAG G 39 and mouse CD31 reverse 59
AGG CCG CTT CTC TTG ACC ACT T 39. RT-PCR reactions
were carried out using the OneStep RT-PCR Kit (Qiagen,
Valencia, CA) containing a final concentration of primer at 0.5
mM. 100 ng of RNA was treated with RQ1 RNase-Free DNase
(Promega, Madison, WI) prior to addition of the RT-PCR
reaction mix. RT-PCR reactions were performed as follows:
30 min at 50uC (reverse transcription); 15 min at 95uC (heat
inactivation of reverse transcriptase and activation of Taq
polymerase); 35–40 amplification cycles of 30 sec at 95uC followed
by 30 seconds of 48uC–50uC (dependent on the Tm of the primer
set) followed by one min at 72uC and a single incubation for
10 minutes at 72uC. No template and no RT controls were
included for each PCR and were negative.
Transmission electron microscopy
Cells were pelleted (five minutes, 2086g), resuspended in 1 mL
PBS, and pelleted again (five minutes, 2086g). Supernatant was
removed and 2.5% glutaraldahyde solution (adjusted to pH 7.4
using HCl and to 400 mOsm using CaCl2) added. Samples were
processed and imaged by Dr. Gary Mierau, The Children’s
Hospital Department of Pathology/Laboratory Services, Aurora,
CO. Briefly, samples were post-fixed in 2% cacodylate buffered
osmium tetroxide (pH 7.4), dehydrated in a graded series of
alcohols, and embedded in epoxy resin. Sections, approximately
80 nminthickness,werestainedwithuranylacetateandleadcitrate
prior to examination at 60 kV with a Zeiss EM-10 transmission
electron microscope (Carl Zeiss Inc, Thornwood, NY).
Enrichment of lung endothelial cells from infected mice
Lung tissues were removed from CD8-alpha knock-out mice six
days post-intranasal inoculation of 1610
6 PFU cHV68. Tissues
were enzymatically digested and endothelial cells purified using
the endothelial cell marker CD31 (PECAM-1) (Fig. S4A). Briefly,
cells were stained with the following antibodies: anti-CD31-biotin
(PECAM-1, clone MEC 13.3, rat IgG2a k) (BD Bioscience), anti-
CD45-PE (B220, clone RA3-6B2, Rat IgG2a k) (BD Bioscience),
anti-F4/80-PE (clone BM8, Rat IgG2a k) (eBioscience, San Diego,
CA), anti-CD4-PE (L3T4, clone RM4-5, Rat IgG2a k)
(eBioscience), anti-CD8a-PE (Ly-2, clone 53-6.7, Rat IgG2a k)
(BD Bioscience), and anti-Ly-6G and Ly-6c-PE (Gr-1, clone RB6-
8C5, Rat IgG2b k) (BD Bioscience). Cells were magnetically
labeled with Anti-Biotin MultiSort beads, separated with Octo-
MACS separation unit, and released from the MultiSort beads as
per manufacturer’s instructions (Miltenyi Biotec Inc., Auburn,
CA). Released cells were incubated with Anti-PE MultiSort beads
and depleted of contaminating PE positive cells by magnetic
separation. Flow cytometric analysis was performed to confirm
flow through fraction from PE column as enriched in CD31
positive cells and depleted of PE positive cells (Fig. S5B).
Limiting dilution nested PCR detection of cHV68
genome-positive cells
The frequency of lung cells from CD8-alpha knock-out mice
containing cHV68 genome was determined using a previously
described nested PCR assay (LD-PCR) with single-copy sensitivity
to detect gene 50 of cHV68 [77]. Briefly, freshly isolated cells were
counted, resupsended in isotonic solution, and then diluted in 10
4
uninfected NIH 3T12 cells prior to serial dilution plating. Plated
cells were lysed overnight in proteinase K, followed by two rounds
of nested PCR. Reactions were performed on 12 replicates per
dilution per sample and products resolved on a 2% agarose gel and
identified by ethidium bromide staining. PCR sensitivity was
quantitated using 10, 1, or 0.5 copies of a gene 50 containing
plasmid (pBamH I N) diluted in 10
4 uninfected NIH 3T12 cells.
Statistical analysis
Data were analyzed using GraphPad Prism software (GraphPad
Software, San Diego, CA). Data were analyzed using the paired
Student’s t test to determine statistical significance. Limiting dilution
data were subjected to nonlinear regression analysis, and the
frequency of genome-positive cells was calculated using the Poisson
distributiontoassumethatthecellnumberatwhich63.2%ofevents
were detected corresponded to the occurrence of a single event.
Accession numbers
PECAM-1: NP_001027550; NM_001032378
ICAM-1: NP_034623; NM_010493
VCAM-1: NP_03523; NM_011693
b-actin: NP_031419; NM_007393
Thy1: NP_033408; NM_009382
Rn18s: NR_003278
CypA: NP_032933; NM_008907
cHV68 WUMS complete genome: U97553
cHV68 v-cyclin: AAB66456
cHV68 gB: AAB06229; U08990
cHV68 gp150: AAC42214; L47321
cHV68 M2: AAF19270
cHV68 M3: AAF1271; AF127083
cHV68 ORF50: NC_001826.2; NP_04487.1
Supporting Information
Text S1
Found at: doi:10.1371/journal.ppat.1000152.s001 (0.03 MB
DOC)
Protocol S1 Isolation and characterization of endothelial cells
from murine lung tissue.
Found at: doi:10.1371/journal.ppat.1000152.s002 (0.03 MB
DOC)
Figure S1 Schematic of conditions for culturing non-adherent
cells following cHV68 infection. Non-adherent cells collected at
six days post-infection, MOI=5PFU/cell were cultured as
described in Materials and Methods.
Found at: doi:10.1371/journal.ppat.1000152.s003 (0.04 MB TIF)
Figure S2 RT-PCR analysis of cyclophilin A transcript in
infected cells. 100 ng of total RNA from mock infected and
infected MB114 and 3T3 cells was added to each RT reaction
along with primers specific for the cellular transcript cyclophilin A.
No RT and no template controls are indicated.
Found at: doi:10.1371/journal.ppat.1000152.s004 (1.88 MB TIF)
Figure S3 Cellular and viral protein expression following
cHV68 infection. (A) MB114 cells contained viral proteins as far
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expression. 20 mg of total protein from mock infected and infected
MB114 and 3T3 cells and from S11 cells were loaded per lane and
blots probed with antibodies to cHV68 v-cyclin (top) and mouse b-
actin (bottom). Mock infected cells were collected at 24 hours.
Latent S11 cells do not express lytic viral proteins and served as a
negative control. (B) The viral cyclin is not required for surface
protein expression changes on infected endothelial cells. MB114
cells harvested at six days post-infection with v-cyclin.STOP
cHV68 were analyzed for cell surface expression of Thy1, ICAM-
1, and VCAM-1 by flow cytometry. Fluorescence was determined
relative to unstained cells (grey). Results are representative from
two independent experiments.
Found at: doi:10.1371/journal.ppat.1000152.s005 (2.98 MB TIF)
Figure S4 Isolation and characterization of primary murine lung
endothelial cells for ex vivo culture. (A) Primary murine lung
endothelial cells were isolated for ex vivo studies as described in
Protocol S1. (B) Light micrographs of primary lung endothelial
cells following isolation (top panel, 40X) and at confluence (bottom
panel, 10X). (C) Analysis of cell surface protein expression in 3T3
fibroblast cell lines (negative control, left panel), CD3 lung
endothelial cell lines (positive control, middle), and primary lung
cells (right panel) by flow cytometry. Endothelial cell specific
markers included CD31 and CD54. CD80 and CD86 were
included as non-endothelial cell specific markers, though a
previous report has identified low level CD80 expression on
primary murine lung endothelial cells [71]. Fluorescence was
determined relative to unstained cells (grey). Cell morphology and
surface expression was similar to previously characterized primary
endothelial cells [71].
Found at: doi:10.1371/journal.ppat.1000152.s006 (0.89 MB TIF)
Figure S5 Isolation and characterization of murine lung
endothelial cells infected in vivo. (A) Primary murine lung
endothelial cells were isolated for analysis of infection in vivo as
described in Materials and Methods. Lung cells were stained for
the endothelial cell marker CD31, as well as with a cocktail of PE
labeleled antibodies specific to the following cell types (which
includes potential contaminating infected cells): macrophages,
granulocytes, CD8
+ T lymphocytes, CD4
+ T lymphocytes, and B
lymphocytes. CD31 positive cells were enriched from total lung
cells and then finally depleted of cells stained with the PE cocktail.
(B) Flow cytometric analysis of lung cell separation following in vivo
infection was performed on total lung cells and PE depleted/
CD31+ enriched cells. Left and middle panels show representative
data (1610
6 cells per stain) from an infected mouse (Fig. 8D).
Gates were set on unstained cells, and data are representative of
the four mice analyzed in Fig. 8D. Splenocytes (right panel) were
included as a staining control.
Found at: doi:10.1371/journal.ppat.1000152.s007 (0.20 MB TIF)
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